论文部分内容阅读
白细胞介素4（IL－4）可抑制骨髓瘤细胞增殖［‘，其作用机理为抑制白细胞介素6（IL－6）分泌，而可溶性白介素6受体（SIL－6R）可以与IL－6起协同作用，增强IL－6的生物效应［‘。因此，探讨IL－4、IL－6和SIL－6R在食管癌患者血清中手术前后的水平，了解该病在发生、发展中这
Interleukin 4 (IL-4) inhibits myeloma cell proliferation [’, its mechanism of action is inhibition of interleukin 6 (IL-6) secretion, and soluble interleukin 6 receptor (SIL-6R) can interact with IL-6 Synergistically enhances the biological effects of IL-6 [’. Therefore, to investigate the levels of IL-4, IL-6 and SIL-6R in the serum of esophageal cancer patients before and after surgery, and to understand the occurrence and development of this disease.